|
|
Article: PROTEIN STRUCTURE MAY LEAD TO TREATMENT FOR INFECTION TARGETING CYSTIC FIBROSIS PATIENTS
- Article from:
- US Fed News Service, Including US State News
- Article date:
- June 9, 2006
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
The U.S. Department of Energy's Argonne National Laboratory issued the following press release:
Researchers at the U.S. Department of Energy's Argonne National Laboratory have determined the structure of a key protein believed to play a role in a deadly infection that afflicts the lungs of cystic fibrosis patients. This finding, published in today's issue of Science, may lead to a new drug to treat the bacterial infection.
Pseudomonas aeruginosa, a pathogen that infects more than 80 percent of cystic fibrosis patients, is a leading cause of these patients' deaths. P. aeruginosa is difficult to treat because it is resistant to many drugs.
While working through a number of pathogenic ...